Skip to main content
Top
Literature
1.
go back to reference Kawasaki Y. The pathogenesis and treatment of pediatric Henoch–Schönlein purpura nephritis. Clin Exp Nephrol. 2011;15(5):648–57.PubMedCrossRef Kawasaki Y. The pathogenesis and treatment of pediatric Henoch–Schönlein purpura nephritis. Clin Exp Nephrol. 2011;15(5):648–57.PubMedCrossRef
2.
go back to reference Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch–Schönlein nephritis. Pediatrics. 2003;111(4):785–9.PubMedCrossRef Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch–Schönlein nephritis. Pediatrics. 2003;111(4):785–9.PubMedCrossRef
3.
go back to reference Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ. Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch–Schönlein nephritis in children. J Clin Pathol. 2005;58(11):1147–51.PubMedCrossRef Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ. Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch–Schönlein nephritis in children. J Clin Pathol. 2005;58(11):1147–51.PubMedCrossRef
4.
go back to reference Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch–Schönlein purpura. Scand J Rheumatol. 2006;35(1):56–60.PubMedCrossRef Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch–Schönlein purpura. Scand J Rheumatol. 2006;35(1):56–60.PubMedCrossRef
Metadata
Title
What should be the indications for fibrinolytic therapy in children with severe Henoch–Schönlein purpura nephritis?
Authors
Se Jin Park
Jae Il Shin
Publication date
01-04-2012
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2012
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0608-4

Other articles of this Issue 2/2012

Clinical and Experimental Nephrology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.